|Videos|May 27, 2023
Discussing Rapid Accurate mRNA Potency Assay Possibilities with Sean Hart
Author(s)Chris Spivey
Sean Hart, CEO and SCO of LumaCyte, discusses rapid accurate mRNA potency assay possibilities.
Advertisement
Chris Spivey, editorial director, speaks with Sean Hart, CEO and SCO of LumaCyte, on the topic of rapid accurate mRNA potency assay possibilities.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FAQ: Pharmaceutical Outsourcing Trends and Innovations
2
Lilly Launches UK Trial of Weight-Loss Drug as US Price Drops
3
FAQ: Everything to Know about 3D Printing in Pharma Manufacturing and Packaging
4
Live Cell High-Content Imaging is Driving Drug Discovery
5
